According to Zacks, “Yield10 Bioscience, Inc. is an agricultural bioscience company. It focuses on the development of disruptive technologies for improvement in crop yield to enhance global food security. The company is working on new approaches, to improve fundamental elements of plant photosynthetic efficiency and optimizing carbon metabolism for better production. It operates primarily in Saskatoon, Saskatchewan, Canada. Yield10 Bioscience, Inc., formerly known as Metabolix, Inc., is based in Woburn, Massachusetts. “
A number of other research firms have also recently commented on YTEN. Maxim Group set a $9.00 price target on shares of Pitney Bowes and gave the stock a “buy” rating in a report on Friday, May 31st. National Securities restated a “buy” rating and issued a $10.00 price target on shares of Aqua Metals in a report on Friday, May 10th.
Yield10 Bioscience (NASDAQ:YTEN) last posted its quarterly earnings results on Thursday, May 9th. The specialty chemicals company reported ($0.22) EPS for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.01. The business had revenue of $0.12 million during the quarter. Yield10 Bioscience had a negative net margin of 1,474.19% and a negative return on equity of 126.91%. On average, research analysts forecast that Yield10 Bioscience will post -0.58 EPS for the current year.
Yield10 Bioscience Company Profile
Yield10 Bioscience, Inc, an agricultural bioscience company, engages in developing disruptive technologies for enhancing crop yield in the United States and Canada. The company, through its Smart Carbon Grid for Crops and T3 platforms, is involved in improving fundamental crop yield through enhanced photosynthetic carbon capture, as well as increased carbon utilization efficiency to increase seed yield.
Further Reading: What are the Benefits of Index Funds?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Yield10 Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yield10 Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.